We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+5.1%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$5.88B
AUM Growth
+$1.01B
Cap. Flow
+$924M
Cap. Flow %
15.72%
Top 10 Hldgs %
9.87%
Holding
605
New
228
Increased
122
Reduced
115
Closed
133

Top Buys

Rank Stock Value
1
HAL icon
Halliburton
HAL
+$60.1M
2
CLR
CONTINENTAL RESOURCES INC.
CLR
+$53.5M
3
APD icon
Air Products & Chemicals
APD
+$52.9M
4
HDS
HD Supply Holdings, Inc.
HDS
+$50.6M
5
ALLY icon
Ally Financial
ALLY
+$49.9M

Top Sells

Rank Stock Value
1
CNQR
CONCUR TECHNOLOGIES INC
CNQR
+$61.6M
2
TQNT
TRIQUINT SEMICONDUCTOR INC
TQNT
+$53.4M
3
SHPG
Shire pic
SHPG
+$51.9M
4
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
+$50.2M
5
BLMN icon
Bloomin' Brands
BLMN
+$42.5M

Sector Composition

Rank Sector Weight
1 Healthcare 14.61%
2 Financials 12.78%
3 Industrials 11.19%
4 Technology 9.23%
5 Consumer Discretionary 8.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRN icon
451
Trinity Industries
TRN
$2.38B
$405K 0.01%
20,102
-368,039
-95% -$8.88M
RLJE
452
CALL
DELISTED
RLJ Entertainment, Inc.
RLJE
$398K 0.01%
66,667
– –
CJES
453
DELISTED
C&J ENERGY SVCS LTD
CJES
$390K 0.01%
+29,494
New +$526K
LPG icon
454
Dorian LPG
LPG
$1.96B
$386K 0.01%
27,798
-80,831
-74% -$1.16M
SIEN
455
DELISTED
Sientra, Inc.
SIEN
$386K 0.01%
+2,296
New +$392K
FATE icon
456
Fate Therapeutics
FATE
$326M
$385K 0.01%
76,494
+25,012
+49% +$110K
TLOG
457
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
$368K 0.01%
76,368
-2,828
-4% -$12.7K
NDLS icon
458
Noodles & Co
NDLS
$107M
$367K 0.01%
+1,742
New +$324K
AFMD
459
DELISTED
Affimed
AFMD
$359K 0.01%
5,793
-4,207
-42% -$240K
MRD
460
DELISTED
MEMORIAL RESOURCE DEV CORP COM STK (DE)
MRD
$344K 0.01%
+19,065
New +$426K
NSM
461
DELISTED
Nationstar Mortgage Holdings
NSM
$324K 0.01%
+11,479
New +$355K
CYTO
462
DELISTED
Altamira Therapeutics Ltd
CYTO
$234K ﹤0.01%
+1
New +$353K
LNG icon
463
Cheniere Energy
LNG
$52.9B
$221K ﹤0.01%
+3,138
New +$221K
USAC icon
464
USA Compression Partners
USAC
$3.74B
$220K ﹤0.01%
13,235
-35,618
-73% -$741K
CYTK icon
465
Cytokinetics
CYTK
$10.4B
$219K ﹤0.01%
27,327
-3,554
-12% -$15.3K
NEO icon
466
NeoGenomics
NEO
$2.13B
$216K ﹤0.01%
51,695
-297,245
-85% -$1.37M
CBIO
467
Crescent Biopharma
CBIO
$626M
$209K ﹤0.01%
290
-11
-4% -$8.61K
IMPR
468
DELISTED
IMPRIVATA, INC COM
IMPR
$188K ﹤0.01%
14,468
-35,532
-71% -$492K
QURE icon
469
uniQure
QURE
$3.22B
$172K ﹤0.01%
11,620
-430
-4% -$5.26K
GNCA
470
DELISTED
Genocea Biosciences, Inc.
GNCA
$169K ﹤0.01%
3,014
-111
-4% -$7.58K
AKAO
471
DELISTED
Achaogen Inc
AKAO
$169K ﹤0.01%
12,935
-479
-4% -$4.87K
HIG icon
472
CALL
Hartford Financial Services
HIG
$39.3B
$38K ﹤0.01%
900
– –
AA icon
473
Alcoa
AA
$13.2B
– –
-69,684
Closed -$2.69M
AAL icon
474
CALL
American Airlines Group
AAL
$10.6B
– –
-147,400
Closed -$5.23M
AAL icon
475
PUT
American Airlines Group
AAL
$10.6B
– –
-187,100
Closed -$6.64M
17 18
19
20 21

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q4 2014 Portfolio in Review

As of Q4 2014, Alyeska Investment Group held 605 positions worth $5.88B, up 21% from $4.86B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Alyeska Investment Group deployed $924M of net new capital in Q4 2014, opening 228 new positions and adding to 122 existing holdings. Its largest new stake was Halliburton: 1,234,449 shares worth $48.6M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 13% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Bloomin' Brands, an estimated $42.5M trimmed.

  • Alyeska Investment Group's largest Q4 2014 buy was Halliburton: 1,234,449 shares worth $48.6M.
  • Alyeska Investment Group added most to HD Supply Holdings, Inc. in Q4 2014, an estimated $50.6M increase.
  • Alyeska Investment Group's biggest Q4 2014 reduction was Bloomin' Brands, cutting an estimated $42.5M.
  • Alyeska Investment Group fully exited CONCUR TECHNOLOGIES INC in Q4 2014, selling an estimated $61.6M.
  • Alyeska Investment Group's ten largest holdings make up 9.9% of its $5.88B portfolio in Q4 2014.
  • Alyeska Investment Group opened 228 new positions and closed 133 in Q4 2014.
  • Alyeska Investment Group's portfolio value rose 21% quarter-over-quarter to $5.88B.

Based on Alyeska Investment Group's 13F filing for Q4 2014, filed 17 Feb 2015.